Preclinical services in oncology

in vitro preclinical services

© Antineo 2018

Antineo’s in vitro preclinical services provide a full suite of assays, and about 120 tumour models. This suite of services is intended to help you refine as much as possible the study design or your in vivo Proof of Concept studies. They allow you to select you lead compounds in a time and cost-effective context, and to obtain the best results from the subsequent in vivo studies

Our offer includes

  • Development of immunotherapies
  • End-point studies
  • Continuous-monitoring studies
  • A bank of 120 tumour models, human and murine
  • Development of resistant tumour cell lines
  • Characterisation of samples